Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

It is very important to explore how we can reduce urinary albumin excretion which is an independent risk factor for ischemic heart disease. In this study, we retrospectively evaluated the effects of RAS inhibitor therapy on diabetic nephropathy in Japanese subjects whose urinary albumin levels were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirukawa, Hidenori, Kamei, Shinji, Kimura, Tomohiko, Obata, Atsushi, Kohara, Kenji, Tatsumi, Fuminori, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247477/
https://www.ncbi.nlm.nih.gov/pubmed/30525055
http://dx.doi.org/10.1155/2018/9435401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247477/
https://www.ncbi.nlm.nih.gov/pubmed/30525055
http://dx.doi.org/10.1155/2018/9435401

Ejemplares similares